Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Different levels of various glucocorticoid-regulated genes in corticotroph adenomas.

Evang JA, Bollerslev J, Casar-Borota O, Lekva T, Ramm-Pettersen J, Berg JP.

Endocrine. 2013 Aug;44(1):220-7. doi: 10.1007/s12020-012-9871-0.

PMID:
23315031
2.

Reduced levels of E-cadherin correlate with progression of corticotroph pituitary tumours.

Evang JA, Berg JP, Casar-Borota O, Lekva T, Kringen MK, Ramm-Pettersen J, Bollerslev J.

Clin Endocrinol (Oxf). 2011 Dec;75(6):811-8. doi: 10.1111/j.1365-2265.2011.04109.x.

PMID:
21595730
3.

Expression of genes related to corticotropin production and glucocorticoid feedback in corticotroph adenomas of dogs with Cushing's disease.

Teshima T, Hara Y, Takekoshi S, Teramoto A, Osamura RY, Tagawa M.

Domest Anim Endocrinol. 2009 Jan;36(1):3-12. doi: 10.1016/j.domaniend.2008.08.002.

PMID:
18818046
4.

Interleukin-6 is inhibited by glucocorticoids and stimulates ACTH secretion and POMC expression in human corticotroph pituitary adenomas.

Pereda MP, Lohrer P, Kovalovsky D, Perez Castro C, Goldberg V, Losa M, Chervín A, Berner S, Molina H, Stalla GK, Renner U, Arzt E.

Exp Clin Endocrinol Diabetes. 2000;108(3):202-7.

PMID:
10926317
5.

Cyclin E-Mediated Human Proopiomelanocortin Regulation as a Therapeutic Target for Cushing Disease.

Liu NA, Araki T, Cuevas-Ramos D, Hong J, Ben-Shlomo A, Tone Y, Tone M, Melmed S.

J Clin Endocrinol Metab. 2015 Jul;100(7):2557-64. doi: 10.1210/jc.2015-1606.

PMID:
25942479
6.

Gene and protein expression in pituitary corticotroph adenomas: a systematic review of the literature.

Seltzer J, Ashton CE, Scotton TC, Pangal D, Carmichael JD, Zada G.

Neurosurg Focus. 2015 Feb;38(2):E17. doi: 10.3171/2014.10.FOCUS14683. Review.

PMID:
25639319
7.

Glucocorticoid inhibition of ACTH peptides: small cell lung cancer cell lines are more resistant than pituitary corticotroph adenoma cells.

Farrell WE, Stewart MF, Clark AJ, Crosby SR, Davis JR, White A.

J Mol Endocrinol. 1993 Feb;10(1):25-32.

PMID:
8383976
8.

Defective expression of prohormone convertase 1/3 in silent corticotroph adenoma.

Tateno T, Izumiyama H, Doi M, Akashi T, Ohno K, Hirata Y.

Endocr J. 2007 Dec;54(5):777-82.

9.

Differential regulation of proopiomelanocortin and pituitary-restricted transcription factor (TPIT), a new marker of normal and adenomatous human corticotrophs.

Vallette-Kasic S, Figarella-Branger D, Grino M, Pulichino AM, Dufour H, Grisoli F, Enjalbert A, Drouin J, Brue T.

J Clin Endocrinol Metab. 2003 Jul;88(7):3050-6.

PMID:
12843142
10.

In situ hybridization study of pro-opiomelanocortin (POMC) gene expression in human pituitary corticotrophs and their adenomas.

Stefaneanu L, Kovacs K, Horvath E, Lloyd RV.

Virchows Arch A Pathol Anat Histopathol. 1991;419(2):107-13.

11.

The pituitary V3 vasopressin receptor and the corticotroph phenotype in ectopic ACTH syndrome.

de Keyzer Y, Lenne F, Auzan C, Jégou S, René P, Vaudry H, Kuhn JM, Luton JP, Clauser E, Bertagna X.

J Clin Invest. 1996 Mar 1;97(5):1311-8.

12.

Clinical, hormonal and molecular characterization of pituitary ACTH adenomas without (silent corticotroph adenomas) and with Cushing's disease.

Raverot G, Wierinckx A, Jouanneau E, Auger C, Borson-Chazot F, Lachuer J, Pugeat M, Trouillas J.

Eur J Endocrinol. 2010 Jul;163(1):35-43. doi: 10.1530/EJE-10-0076.

13.
14.

Inhibition of heat shock protein 90 decreases ACTH production and cell proliferation in AtT-20 cells.

Sugiyama A, Kageyama K, Murasawa S, Ishigame N, Niioka K, Daimon M.

Pituitary. 2015 Aug;18(4):542-53. doi: 10.1007/s11102-014-0607-4.

PMID:
25280813
15.

[Pathology and pathogenesis of pituitary corticotroph adenoma].

Trouillas J.

Neurochirurgie. 2002 May;48(2-3 Pt 2):149-62. Review. French.

PMID:
12058122
16.
17.

HDAC2 expression and variable number of repeats in exon 1 of the HDAC2 gene in corticotroph adenomas.

Evang JA, Borota OC, Melum E, Holm R, Ramm-Pettersen J, Bollerslev J, Berg JP.

Clin Endocrinol (Oxf). 2010 Aug;73(2):229-35. doi: 10.1111/j.1365-2265.2010.03805.x.

PMID:
20346000
18.

Differential gene expression in ACTH -secreting and non-functioning pituitary tumors.

Tateno T, Izumiyama H, Doi M, Yoshimoto T, Shichiri M, Inoshita N, Oyama K, Yamada S, Hirata Y.

Eur J Endocrinol. 2007 Dec;157(6):717-24.

19.

Liver X receptor-α/β expression ratio is increased in ACTH-secreting pituitary adenomas.

Hashimoto K, Matsumoto S, Ishida E, Miura A, Horiguchi K, Ozawa A, Shibusawa N, Satoh T, Yamada M, Yamada S, Mori M.

Neurosci Lett. 2011 Apr 20;494(1):34-7. doi: 10.1016/j.neulet.2011.02.048.

PMID:
21356276
20.
Items per page

Supplemental Content

Support Center